Formoterol fumarate dihydrate
SIGMA/F9552 - >98% (HPLC)
Synonym: (R*,R*)
CAS Number: 183814-30-4
Empirical Formula (Hill Notation): C19H24N2O4 · 0.5C4H4O4 · H2O
Molecular Weight: 420.46
MDL Number: MFCD11045919
Linear Formula: C19H24N2O4 · 0.5C4H4O4 · H2O
Product Type: Chemical
| assay | >98% (HPLC) |
| color | white to off-white |
| form | solid |
| InChI | 1S/2C19H24N2O4.C4H4O4.2H2 |
| InChI key | RATSWNOMCHFQGJ-TUYNVFRMSA |
| originator | Novartis |
| Quality Level | 100 ![]() |
| SMILES string | O.O.OC(=O)C=CC(O)=O.COc |
| solubility | DMSO: soluble 20 mg/mL |
| H2O: insoluble |
| Application: | Formoterol fumarate dihydrate has been used: • as ß2-adrenergic agonist, to determine whether ß2-adrenergic receptor signaling was sufficient to induce up-regulation of select gene transcripts • as a ß2-adrenergic receptor agonist and a long term bronchodilator • as ß2-adrenergic receptor (ß2AR) agonist to recover renal function in ischemia-reperfusion injury (IRI) in mice |
| Biochem/physiol Actions: | β2-Adrenoreceptor agonist. |
| Biochem/physiol Actions: | Formoterol fumarate dihydrate can be used along with budesonide to treat asthma. |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 10, 50 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | >98% (HPLC) |
| UNSPSC | 12352200 |

